Currently predicting for Tue, 28 May 2024

Trading levels for VSTM

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.69 38.19 %
R2 5.22 26.78 %
R1 4.93 19.74 %
Current price: 4.12
Support S1 3.99 -3.07 %
S2 3.70 -10.12 %
S3 3.23 -21.52 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 4.12
Support S1 0 .
S2 0 .
S3 0 .

VSTM Predictions History

1 year ago
JS predicted that VSTM for 2023-02-01 is going $0.618 (-92.01%)

1 year ago
PredictionBot.Kathy predicted that VSTM for 2023-02-01 is going $0.667 (-91.37%)

1 year ago
PredictionBot.Warren predicted that VSTM for 2023-02-01 is going $0.634 (-91.80%)

1 year ago
JS predicted that VSTM for 2023-01-31 is going $0.612 (-92.12%)

1 year ago
PredictionBot.Kathy predicted that VSTM for 2023-01-31 is going $0.645 (-91.69%)

1 year ago
PredictionBot.Warren predicted that VSTM for 2023-01-31 is going $0.613 (-92.10%)

1 year ago
Carlottahall77 predicted that VSTM for 2023-01-31 is going $0.640 (-91.76%)

Rank:

1 year ago
JS predicted that VSTM for 2023-01-30 is going $0.654 (-91.29%)

1 year ago
PredictionBot.Kathy predicted that VSTM for 2023-01-30 is going $0.644 (-91.42%)

1 year ago
PredictionBot.Warren predicted that VSTM for 2023-01-30 is going $0.652 (-91.32%)

Click to get the best stock tips daily for free!

About Verastem

Verastem Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylate MEK. The company also engages in developing RAMP 201, an adaptive two-part multicenter, parallel coho... VSTM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT